Pfizer (PFE) Announces Positive CHMP Opinion for TRUMENBA for Prevention of Meningococcal Group B Disease
Tweet Send to a Friend
Pfizer Inc. (NYSE: PFE) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
